FDA Inspection
AGC Pharma Chemicals Europe, S.L.U.AGC Pharma Chemicals Europe, S.L.U. – FDA Inspection, May 25, 2018
Record Details
This FDA Inspection record concerns AGC Pharma Chemicals Europe, S.L.U., with an inspection on May 25, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA McCulloughJ (Issuing Officer)
View Company Profile
ID · 3a42665b-48e2-437b-80d3-5a3eca9d7fba
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1159666
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AGC Pharma Chemicals Europe, S.L.U.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2023 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| May 26, 2017 | Not classified | Office of Inspections and Investigations | |
| September 25, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 16, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AGC Pharma Chemicals Europe, S.L.U.
- FDA Inspection 1276708 - 2024-05-16
- FDA Inspection 1225598 - 2023-11-20
- FDA Inspection 1016455 - 2017-05-26
- FDA Inspection 943998 - 2015-09-25
- FDA Inspection 601778 - 2009-07-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.